Rehabilitation interventions such as exercise, weight reduction and pharmacotherapy are recognised ways of managing comorbidity-related conditions after cancer treatment (Alamuddin, Bakizada, & Wadden, 2016) , and there is evidence that smoking cessation (Sitas et al., 2014) reduces adverse treatment effects and improves survival. Preparing patients prior to cancer therapy by improving their overall health status as in prehabilitation could optimise their response to treatment and has important implications for future service delivery (Silver & Baima, 2013) . Prehabilitation has been espoused as a key component of early recovery in cancer patients and is a term that has been traditionally used to describe interventions for optimising cardiopulmonary reserve prior to cancer surgery, with the aim of improving post-operative recovery outcomes (Carli et al., 2017; Silver, 2015; Silver & Baima, 2013) . However, prehabilitation programmes are also targeting this pre-treatment period to improve chemotherapy adherence (Le Roy et al., 2016) , reduce anxiety (Tsimopoulou et al., 2015) and to provide a stronger platform for post-treatment rehabilitation aimed at reversing treatment-related side effects and symptoms, managing comorbidities and enhancing longer-term health-related quality of life (Alfano, Ganz, Rowland, & Hahn, 2012; Boereboom, Williams, Leighton, & Lund, 2015; Shun, 2016; Silver, 2014) . While fewer studies have been undertaken outside of the surgical context, a growing number of studies are focusing on different cancer treatments and modes of prehabilitation using exercise, psychological support and nutritional interventions.
These studies need to look at longer-term outcomes beyond the traditional enhanced recovery 30 days post-treatment outcomes, to understand treatment adherence, mortality, disease prognosis or impact on health economics (Stout et al., 2018) . This is the first systematic review to critically review the impact of different prehabilitation interventions on long-term health outcomes (at or beyond 30 days post-treatment completion) in cancer patients and explore the utility of prehabilitation as a platform for risk management before and after all cancer treatments.
This review addressed two questions:
1.
What is the effect of prehabilitation on ≥30 days post-treatment outcomes including physical functioning, nutrition and patientreported outcomes?
2. How can prehabilitation be used to optimise the management of cancer patients with comorbidity or pre-existing risk factors that are associated with poorer cancer treatment outcomes?
| ME THODS

| Data Sources and search method
The review was registered on PROSPERO (CRD42016050296) international prospective database of systematic reviews. The search was conducted in two stages. In stage one, studies were identified via abstracts through a systematic search strategy for Medline (Pub med),
CINAHL (with full text) EMBASE and Cochrane central register of
controlled trials. The databases were chosen to identify potentially relevant published studies in the field of medicine, exercise, health and psychosocial care. Search terms were split into two categories "prehabilitation combined with cancer" and terms to identify the nature of prehabilitation such as "exercise, nutrition, psychology and other behavioural interventions," The full search strategy and MESH terms are provided in supplementary materials. In stage two, other relevant publications were retrieved by reviewing the reference lists of these studies against the eligibility criteria.
Studies selected were published from the period 2000 to February 2017. The following were all excluded from the review: prehabilitation studies with no reported post-treatment outcomes at 30 days or longer; studies that combined data from previously published studies; and abstracts, case studies, conference abstracts and those not in English. Participants included were cancer patients who were treated with any treatment modality and received any form of prehabilitation either in the home or hospital setting. Prehabilitation was defined as a single-or multi-modality intervention that could include exercise, nutritional support, patient education and/or psychological therapy. Control was defined as those participant's receiving usual care as defined in the clinical pathway. Identification of objective clinical, patient-reported and delivery outcomes was described at 30 days post-treatment completion. Comorbidity data at baseline and at completion were also reviewed. Efficacy in relation to 30 days post-treatment objective physical functioning was explored through meta-analysis but data were not of sufficient quality to make a F I G U R E 1 PRISMA study selection flow chart comparison. The quality of eligible studies was assessed using the PRISMA critical appraisal methods (Shamseer L et al., 2015) . Risk of bias was assessed by an interdisciplinary research team using the Cochrane Collaboration's tool for assessing risk of bias ROBINS-I tool (Sterne et al., 2016) . Observational or quasi-experimental studies were included as they provided additional information as to the use of prehabilitation interventions.
| RE SULTS
Sixteen randomised controlled trials (RCT) and six observational studies were included in the narrative synthesis (Figure 1 ). The quality of the RCT studies varied considerably with 7 of the 16 studies being considered as having a high risk of bias. Studies were not sufficiently consistent in intervention or outcome data to be included in a meta-analysis. In many studies reporting of the randomisation processes, lack of allocation concealment to those enrolling, blinding of outcome assessors and poor reporting of missing data may have impacted on study quality (Table 1) . Most studies were single-centre studies. However, one of two multi-site studies was a three-arm trial comparing psychological prehabilitation strategies, with participants randomised to stress management, a support group or usual care (Parker et al., 2009) . Other studies compared different prehabilitation components head to head as nutritional interventions or psychological approaches. The number of participants within the RCTs ranged from 48 to 652, with a median of 88 with a total number of subjects in the review of 2017 (Table 1) . Most individual RCTs analysed fewer than 60% of the sample originally recruited in the study, excluding participants due to comorbidity or inability to undergo cardiopulmonary exercise testing. Participants were adults with colorectal (Carli et al., 2010; Cheville et al., 2015; Moriya, 2015) lung (Barlési et al., 2008; Stefanelli et al., 2013) , head and neck (Van Bokhorst-de Van der Schuer et al., 2000) , breast (Garssen et al., 2013) , bladder (Jensen, Krintel Petersen, Jensen, Lausten, & Borre, 2014; Jensen, Petersen, Jensen, Laustsen, & Borre, 2015) and prostate (Bales et al., 2000; Burgio et al., 2006; Parker et al., 2009) cancer or included individuals with a range of cancers (Schmidt et al., 2015) . Trial designs were primarily feasibility studies, and therefore, the studies were rarely powered to determine the efficacy of prehabilitation on post-treatment recovery outcomes. The primary endpoint was predominantly objective physical function prior to treatment with the secondary endpoints described at 1-6 months post-intervention. Only four (25%) of the authors fully reported participant comorbidities at baseline (Burgio et al., 2006; Jensen et al., 2015; Schmidt et al., 2015; Van Bokhorst-de Van der Schuer et al., 2000) while two actively excluded participants with comorbidities possibly due to the intensity of the exercise programme (Carli et al., 2010; Stefanelli et al., 2013) .
The designs of the six observational studies were either casecontrolled cohort, historical controls or quasi-experimental. Studies were primarily feasibility studies, and participant numbers were small, ranging from 35 to 87 with a total of 289 participants. Studies included individuals with breast cancer (Baima et al., 2015) , lung cancer (Jones et al., 2007; Peddle et al., 2009; Sekine et al., 2005) , colorectal cancer (Li et al., 2013) and prostate cancer (Sueppel, Kreder, & See, 2001 ).
Comorbidities were only reported in three of the studies at baseline, with ill health being cited as a contributing factor to difficulties with recruitment rather than this being recorded as an outcome.
Several studies did not report attrition (Sekine et al., 2005; Sueppel et al., 2001) , and among those that did attrition rates ranged from 0% to 52%. The number and combination of prehabilitation modalities varied considerably across studies, ranging from 1 to 3 across individual RCTs and observational studies (Tables 2 and 3 ).
Most (16/22) studies included an exercise modality, either as a stand-alone prehabilitation intervention or in combination. Four studies examined the effects of pelvic floor training in men with prostate cancer over a varying number of weeks before radical prostatectomy (Bales et al., 2000; Burgio et al., 2006; Centemero et al., 2010; Sueppel et al., 2001 ). These were predominantly home-based exercise programmes with some level of instruction and supervision and/or biofeedback training. Two studies incorporated supervised therapeutic pulmonary exercises (in conjunction with more conventional conditioning exercise) in lung cancer patients in the 2-3 weeks prior to surgery (Sekine et al., 2005; Stefanelli et al., 2013) . These exercises were performed on 5-7 days per week and included incentive spirometry, abdominal breathing, huffing and coughing, and respiratory exercises on a bench, mattress pad and wall bars. Finally, a study in breast cancer patients investigated the feasibility of therapeutic shoulder mobility exercises in the 2-4 weeks before surgery, comparing in-person teaching with video-only teaching (Baima et al., 2015) . Both methods were shown to be feasible with high adherence (≥75%). Other studies investigated the effects of conventional forms of exercise conditioning for improving cardiopulmonary fitness and/or muscular strength over durations of 2-8 weeks, though most programmes were of 2-to 4-week duration (Tables 2 and 3 ).
All but one of these studies implemented exercise prehabilitation in the time period before colorectal, lung or bladder cancer surgery, whereas the remaining study (Cheville et al., 2015) focused on adherence to chemoradiotherapy in patients with gastrointestinal cancers. Home-based programmes generally consisted of aerobic and resistance exercise on at least three days per week with varying degrees of face-to-face supervision and telephone support (Carli et al., 2010; Gillis et al., 2014; Li et al., 2013) . Instructions on both the frequency and intensity of aerobic exercise were generally provided, and in some cases, participants used heart rate monitors and perceived exertion scales to self-assess their level of effort (Gillis et al., 2014; Li et al., 2013) . Studies of more closely supervised 2-to 6-week programmes of exercise prehabilitation involved vigorous intensity cycle ergometry in lung (Jones et al., 2007; Peddle et al., 2009 ) and rectal cancer patients (West et al., 2015) prior to surgery and isokinetic muscle strengthening exercises in patients with gastrointestinal cancers during chemoradiotherapy (Cheville et al., 2015) . Two further studies included vigorous gym-based aerobic exercise (Stefanelli et al., 2013) • Anxiety considerably reduced after surgery but did not change in either group over the prehabilitation period.
• Depression improved for the bike/strengthening group over the prehabilitation period.
• Exercise participation bike/strengthening group > walk/ breathing group (p = 0.075).
Lower exercise had better outcomes because of less dropouts, poor compliance in the higher intensity group may have been too hard for such patients • ICS male SF mean score in pre-operative group 8.1 versus post-operative group 12.2.
• Study found that pre-operative PFME improved quality of life (The ICFS is a symptom-based tool)
No detail re-adherence to exercises. The question whether the pre-operative or post-operative had most effect is unclear. Differences persisted for up to 6 months at 1 year there was no difference 
18%
Only 57% of eligible patients finished study At 3 months' post-surgery compared to baseline, the intervention group had:
• Significant difference at 1 month in depression • no significant difference in quality of life • no significant difference in wellbeing • pain not measured at 3 months • control group more complaints than intervention group (0.001 < p<0.01).
At 3 months post-op measures will be affected by start of adjuvant treatment (and no information reported on this). Experience of control measured by author designed 4-item questionnaires (un validated measures). Unable to differentiate effect of intervention content or psychologist intervention.
The study power is not clear against its primary outcome. Targeted intervention. The differences between groups at 3 months are not significant A change of 20 m is considered clinically meaningful as this is the estimated measurement of community-dwelling elderly Limitation of the study is missing data and unclear which modality of prehabilitation responsible for outcomes • Recovery rates were similar between groups in the 4-weeks post-surgery (p = 0.81).
• Comment: intervention focused on building strength. Focus on upper-body strength and not lower body. Post-intervention lack of nutrition may impact on similar group trajectories.
• Pre-surgery results are significant but not sustained at 4 weeks 6 MWT data missing pre-op for four patients (two placebo, two whey) and 12 post-op (four placebo, eight whey), analysis based There was no significant difference in LOS and number of adverse events.
• Physical capacity was significantly improved (p0.02) and mean walking distance at 7 days' post-op.
• At follow-up both groups had regained physical capacity and no difference was seen.
• Patient tailored intervention but unclear as to how this was personalised. Abstract has little information re-intervention.
Just over half (55%) completed the prehab programme at 100%, 59% fulfilled 75%. It would have been useful to compare groups on 6 MWT rather than LOS as primary outcome measure
Frequency: 2× • LOS: no significant difference between both groups (p = 0.99).
• HRQoL: no significant difference between the global HRQoL 12 months after surgery in the intervention and in the control group.
• Post-operative stress: (mobilisation, PONV and post-operative pain). Patients in the intervention group reported less pain on the first post-operative day (75.2% vs. 82.3%, p = 0.03). There were no differences regarding mobilisation within the first 24 hr (69.2% vs. 70.4%, p = 0.73), or PONV within the first five days (52.8% vs. 56.4%, p = 0.39).
• Depression: There was no difference in the geriatric depression scale between intervention and control groups at discharge (p = 0.86).
• Readmission: The readmission rate within 90 days was slightly higher for patients in the intervention group (p = 0.70).
In-hospital length of stay at readmission was shorter than in the standard care group without reaching statistical significance (p = 0.22).
• Mortality: The overall mortality did not differ significantly between the two groups (Log-Rank-test p = 0.197).
Patient empowerment failed to shorted LOS or HRQOL. This type of intervention could enhance quality of care in regard to pain, and since over-treatment of pain is particularly harmful for elderly patients, patient safely can thus be improved. Preoperative information was received well by patients who were cognitively and physically fit TA B L E 2 (Continued) Not reported A significant difference was observed both at T1 and T2.
In prehabilitation group, peak VO 2 improves significantly from T0 to T1, p < 0.001 and deteriorates from T1 to T2, p < 0.001 in control reverting to a similar value to that at T0.
• Control group peak VO 2 did not change from T0 to T1 and significantly deteriorates from T1 to
• T2: p < 0.00001.
• FEV1 NS T0, T1, T2 Currently, other studies are needed to demonstrate that the patients who undergo pre-operative PRP could have also a better quality of life, less post-operative complications and a longer survival after surgery. 
37%
Between baseline and the day before surgery, both pre-operatively fed groups revealed a positive change for physical and emotional functioning and dyspnoea with significance in arginine group. This was not sustained long term at 6 months.
• Supplemented group showed a negative change in appetite (p = 0.049). Between baseline and 6 months after surgery, • There were no differences between control and both pre-fed groups.
There were no differences in favour of arginine supplement compared to other feed group
TA B L E 3 Observational and quasi-experimental prehabilitation studies with critical analysis • 76% chose to exercise.
Reference and research design Intervention and comparator
Population and sample
Follow-up after intervention Attrition
Critical analysis
• No difference in exercise compliance between in-person teaching versus video teaching (OR = 1.03).
In person 75% (24/32) compared to video teaching 77% (10/13) Pain
• 29% of patients (9/31) had worse shoulder pain than baseline at 1 month post-surgery (24%, 6/25 exercisers, and 50%, 3/6 non-exercisers).
• 15% per cent of patients (4/27) had worse shoulder pain than baseline at 3 months' post-surgery (8%, 2/23 exercisers, and 100%, 2/2 non-exercisers). Shoulder abduction Six-minute walk test: Significant improvement in >80% adherence group (p = 0.14) compared to <80% adherence (p = 1.01).
The overall adherence rate was 72% (range, 0%-100%) with patients completing a mean of 30-27 sessions (range, 0-75). No significant difference. (p > 0.1) for all measures of pulmonary function. The average duration of hospital stay was 10-8 days with 8-5 days in general hospital and 2-5 days in the intensive care unit.
No difference in complications or length of stay than in routine patient care. The length of intervention may be problematic in a 1 to 2 week wait time for surgery, the authors comment on the ability to make significant change in such a short time. There is no recording of how many patients did not meet the eligibility parameters to reflect the normal practice (Continues) 
0%
The patients in the prehabilitation programme had better post-operative walking capacity at 8 weeks (mean difference, 84.5 ± 83 m; p < 0.01). At 8 weeks, 81%
of the prehabilitated patients were recovered compared with 40% of the control group (p < 0.01).
The prehabilitation group also reported higher levels of physical activity before and after surgery. The post-operative complication rates and the hospital length of stay were similar. There were significant emotional and social differences between control and intervention. These are not controlled for in the modelling or analysis of difference. Lack of detail re-nutritional component. day) (Sekine et al., 2005) in combination with therapeutic pulmonary exercises in patients with lung cancer prior to surgery. The short timelines prior to therapy made a progressive programme difficult to achieve. Although adherence to the home exercise programme was reported in most of these studies, adherence to exercise at the prescribed intensity and progression of the exercise programme were poorly reported.
Only five of the studies provided a nutritional modality as part of the prehabilitation package. Some of the interventions were purely nutrition based Moriya, 2015; Van Bokhorst-de Van der Schuer et al., 2000) ; however, two of the studies used nutrition as part of multi-component prehabilitation intervention Li et al., 2013) . The nutritional interventions were varied with 5-10 days pre-operative feeding plus a supplemental arginine formula (Van Bokhorst-de Van der Schuer et al., 2000) or whey protein (Gillis et al., 2014; Li et al., 2013) or a low or high dose immune-enhancing diet (Moriya, 2015) . Multi-modal prehabilitation interventions provided 90 min of nutritional counselling with daily whey protein supplementation in comparison with a control group which received nutritional counselling without supplementation. The timing of nutritional interventions varied between 5-10 days Moriya, 2015 ) and 3-6 weeks pre-operatively (Gillis et al., 2014; Li et al., 2013) . The nutritional intervention did not continue beyond surgery, with one exception cancer Li et al., 2013; Moriya, 2015) . Van Bokhorstde Van der Schuer et al. (2000) excluded adults from the study if they were well nourished (10% excluded), whereas Gillis et al. (2016) screened for malnutrition using the Patient Generated-Subjective
Global Assessment (PG-SGA) which is a validated tool for nutritional assessment in oncology. Adherence to nutritional intervention is reported in only one study with researchers contacting participants on a weekly basis to encourage them to record their whey protein ingestion. This study noted that adherence was higher in the prehabilitation group compared to the rehabilitation group both pre-and post-surgery.
Studies involving a psychoeducation modality as part of prehabilitation programmes have focused primarily on anxiety and stress reduction (Cheville et al., 2015; Garssen et al., 2013; Parker et al., 2009; Schmidt et al., 2015) , patient education and lifestyle advice (Baima et al., 2015; Barlési et al., 2008) (Jensen et al., 2015) and/ or counselling (Parker et al., 2009) as part of the intervention; however, few studies report any detail of the therapeutic components of the intervention. Psychoeducational prehabilitation strategies have been studied as single mode counselling interventions (Barlési et al., 2008; Cheville et al., 2015) or by comparing a variety of psychological and educational approaches prior to cancer treatment (Parker et al., 2009 ). Psychoeducational strategies have also been studied as part of multi-component prehabilitation programmes (Gillis et al., 2014; . Psychoeducational interventions prior to surgery for lung and gastrointestinal cancer provided written and verbal information to participants which described the disease and associated surgery outcomes (Barlési et al., 2008; Schmidt et al., 2015) . An alternative psychotherapeutic approach involved weekly group sessions with a psychiatrist, focused on individuals' social, cognitive and emotional care in conjunction with relaxation exercises 30 days prior to chemotherapy (Cheville et al., 2015) . Similarly, Garsen (Garssen et al., 2013) 
| Objective clinical outcomes following prehabilitation
Studies that included an exercise modality investigated the effects of prehabilitation regimens on cancer treatment recovery outcomes and cardiopulmonary fitness (Table 4) . Three studies reported favourable effects of home-based pelvic floor training on post-operative urinary continence outcomes in prostate cancer patients undergoing radical prostatectomy up to 12 months of follow-up (Burgio et al., 2006; Centemero et al., 2010; Sueppel et al., 2001) , and a fourth study (Bales et al., 2000) showed no urinary continence benefits of including biofeedback training. Similarly, a study of female breast cancer patients reported no additional postoperative benefits when home-based shoulder exercise prehabilitation included an in-person teaching session versus video-based instruction (Baima et al., 2015) . Supervised exercise prehabilitation programmes in lung cancer patients have generally been more intensive than home-based programmes and have resulted in improvements in pre-operative cardiopulmonary fitness measures, including six-minute walk test (6 MWT) (Jones et al., 2007) and peak VO 2 (Jones et al., 2007; Stefanelli et al., 2013) . However, the improvements in peak VO 2 were modest (2-3 ml kg Studies that included nutritional outcomes were few and reported no significant differences between the intervention and control groups at ≥30 days (Moriya, 2015) on post-treatment physical functioning (Table 4) . However, pre-operative nutritional modality groups showed a significant improvement in physical functioning and initial symptoms post-operatively (Gillis et al., 2014; Li et al., 2013; Van Bokhorst-de Van der Schuer et al., 2000) .
Only one study measured upper-body strength , and this improved pre-surgery but was not sustained post-surgery.
Participants who received arginine supplementation with feeding pre-and post-surgery showed reduced appetite at 6 months (Van Bokhorst-de Van der Schuer et al., 2000) , and serum albumin remained stable in a small (n = 17) pre-post-intervention study (Li et al., 2013) . However, prehabilitation studies' nutritional outcomes are compromised by the lack of consistency in measuring nutritional intake and adherence (mainly through self-report tools) or objective sarcopenia measures. Such limitations could have important implications for assessing treatment fidelity and the sensitivity of outcome measures.
| Patient-reported outcomes (PRO) of prehabilitation
PRO in the studies reviewed included health-related quality of life using the Short Form Health Survey (SF36) and Prostate Cancer Index (PCI), which incorporate physical and emotional subscales.
Symptom specific measures such as the International Continence
Scale for men (ICS male), the Hospital Anxiety and Depression Scale (HADs) and (PCI) and Activities of Daily Living (ADL) tool were also reported in some studies (Table 4) . Quality of life scores were comparable between prehabilitation and control groups at 3 months post-intervention in most studies (Barlési et al., 2008; Burgio et al., 2006; Garssen et al., 2013; Peddle et al., 2009 ). However, in two studies, self-reported physical function was higher in the prehabilitation group at 1 year (Li et al., 2013; Parker et al., 2009) , and in the study by Li et al. (2013) , an increase in self-reported physical activity persisted 8 weeks after surgery. Post-treatment improvements in mood, anxiety and depression have been reported immediately post-operatively following prehabilitation involving walking + breathing exercises and psychological support (Carli et al., 2010; Parker et al., 2009; Schmidt et al., 2015) but effects were small and between-group differences were not sustained long-term (Parker et al., 2009; Schmidt et al., 2015) . Behavioural change techniques, such as smoking cessation, were rarely reported in studies; this can impact on radiotherapy side effects and subsequent post-treatment cancer outcomes (Warren, Sobus, & Gritz, 2014) . 
Examplesof dimensionmeasures
| Patient-reported and service outcomes for prehabilitation
Complication rates and length of hospital stay (LOS) post-surgery were the most frequent service delivery measures reported for ≥30 days post-treatment (Table 4) . There was no difference in length of stay, between prehabilitation and control groups in five studies Jensen et al., 2014; Li et al., 2013; Schmidt et al., 2015) , with the exception of Sekines (Sekine et al., 2005) , where the intervention group had a reduced length of stay after a 4-to 6-week prehabilitation programme. Post-operative complications such as wound healing, seroma formation and bleeding were shown to be comparable between intervention and control groups but Moriya (Moriya, 2015) found that those receiving a prehabilitation nutritional intervention had fewer post-operative site infections.
Prehabilitation has been shown to improve initial post-operative mobilisation (Jensen et al., 2015) and the number of patients completing chemotherapy (Cheville et al., 2015) . Furthermore, in the latter study, those receiving the intervention had significantly fewer treatment hospitalisations.
| D ISCUSS I ON
Overall, this systematic review suggests prehabilitation impacts on It is now recognised that a physically active lifestyle is inversely related to the risk of certain cancers and mortality (Brown, Winters-Stone, Lee, & Schmitz, 2012; Schmid & Leitzmann, 2014) . Surprisingly few prehabilitation studies measured or reported participant comorbidities and how they changed over time. Therefore, we were unable to address our second question, how prehabilitation can optimise the management of cancer patients with comorbidity? Comorbidities in participants in prehabilitation studies were considered exclusion criteria rather than as predictors of physical functioning that could be mediated by exercise or nutrition and that could change as a response to intervention (Brown et al., 2012) . Those participants with high levels of comorbidities and poor fitness were often not eligible to be included, which suggests those people most in need to improve physical function were less likely to receive prehabilitation. The multi-modality approach of prehabilitation could optimise the management of cancer patients with low baseline scores and who have been shown to gain greater benefits (Minnella et al., 2016) .
Rather than trying to demonstrate the efficacy of multi-modality prehabilitation on the fittest patients, we should consider using the approach to optimise the management of the more complex and least fit cancer patients who have most to gain. This requires more sophisticated tailoring of intervention to personalise and target prehabilitation. For example, current exercise guidelines for cancer survivors recommend muscle strengthening exercises for overall conditioning (Schmitz et al., 2010 ) but this may not be sufficient to manage specific deficits. A more task-specific approach incorporating functional movements using strength and mobility may be optimal for prehabilitation regimens (WintersStone et al., 2015) .
In some studies, the high attrition of participants suggests a balance is required between intensity and duration of exercise to be able to meet the needs of those with greater limitations. This highlights the need for continuity and support in establishing exercise habits and expectations around exercise for people with cancer (Brown et al., 2012; Mayo et al., 2011) . The content of exercise programmes is poorly described in some papers and has not followed the FITT principle of reporting Frequency, Intensity, Timing and Type of exercise and/or how the exercise programme is personalised or progressed over time (Thompson, Gordon, & Pescatello, 2010) . These oversights make it challenging to understand whether or not the exercise programme was insufficiently designed and/or how to revise programmes to optimise adherence and outcomes in the future.
The inclusion of nutritional support as part of prehabilitation improved short-term physical function. The pre-surgical interventions were necessarily short (2-3 weeks) primarily due to treatment target times. Indications from one study suggest that longer-term patient outcomes could benefit with additional post-surgical rehabilitation. Given the rising proportion of cancer patients who are obese at diagnosis, the prehabilitive window and rehabilitative window are potentially an opportunity to embed new lifestyle behaviours. Malnutrition is associated with a poorer response to cancer treatment, and hypoalbuminaemia is associated with postsurgical mortality, increased morbidity and length of stay (Hu et al., 2015) . Patients with colorectal cancer are more malnourished than other patients groups (28% colorectal compared to 4% prostate cancer) (Hu et al., 2015) hence the wide number of prehabilitation studies in this population. In the nutrition components of prehabilitation programmes, surrogate measures were used for the combined interventions rather than specific targets such as serum values or anthropometric measures. If we are tackling obesity in cancer and its risks, then a greater focus on adiposity, fat distribution and sarcopenia should be included in prehabilitation studies. With emerging therapies and earlier diagnosis techniques, for example of low dose computerised imaging in lung cancer (Smith, Khanna, & Wisotzky, 2017) , the opportunity for prehabilitation becomes more feasible as patients are less likely to be burdened by advanced disease or chronic illness.
Understanding how prehabilitation components work together is a challenge as few studies used a theoretical or conceptual frameworks to guide design. Exploring how the multi-modality components work, such as exercise, nutrition, psychoeducational components, is essential to maximise outcomes (Figure 2 ). The use of factorial research designs in future studies is recommended in evaluating prehabilitation components (Montgomery, Peters, & Little, 2003) . While pre-operative exercise programmes have incorporated both aerobic and resistance training, most emphasis has been on aerobic exercise.
The effect of resistance exercise on pre-operative muscular function and how this impacts upon post-operative recovery outcomes has received less attention (Singh et al., 2013) . The relationship between psychological health and exercise behaviour has been well established. Short-and long-term adherence may be optimised if anxiety and depression are also addressed during an exercise programme; however, the focus on anxiety and depression management at the expense of evidence-based behaviour change strategies may not be the best strategy for long-term adherence (Stacey, James, Chapman, Courneya, & Lubans, 2015) .
A limitation of this review is that conclusions have to be considered in the context of a limited number of studies, the majority of which are underpowered feasibility studies. The importance of feasibility studies is recognised in the Medical Research Council (MRC) complex intervention framework and that they should now be used to inform fully powered RCTs. The review highlighted the need for improved quality of studies, for example following consort or strobe reporting guidance, and this has also been described in previous prehabilitation systematic reviews (Singh et al., 2013) .
It is imperative that future studies take a more ambitious approach to test efficacy by building on the current evidence base using a conceptual framework to guide intervention design and robust evaluation.
Can prehabilitation programmes impact on longer-term cancer health outcomes? The answer is currently unclear especially in relation to changing comorbidity. Prehabilitation is now an integral part of many cancer surgical preparatory pathways as part of early recovery but there is scope for greater targeting to include nutrition and psychoeducational components, as well as considering how prehabilitative interventions may buffer symptoms such as fatigue and pain during adjuvant therapies. Sophisticated research designs incorporating economic evaluation and longer-term measures are essential to guide service development and support implementation if the concept of cancer prehabilitation is to emulate cardiac rehabilitation services.
In conclusion, prehabilitation strategies may have an important role to play in addressing the rising complexity of health needs of those diagnosed with cancer. Forty per cent of all those diagnosed with cancer have one comorbid condition and 15% at least two concurrent health problems (Sarfati et al., 2016) . This systematic review highlights that single-and multi-modal prehabilitation programmes are feasible and some approaches confer short-term benefits in the post-surgical recovery period. The next stage is to design robust efficacy studies to test carefully defined prehabilitative/prehabilitative-rehabilitative interventions at the time of first cancer treatment (be that surgery, systemic anti-cancer therapy or radiotherapy) and measure clinical outcome, PRO, patient benefit and service delivery outcomes throughout the care pathway.
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